| mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
8e-08 |
| mRNA |
3-Cl-AHPC |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
2e-07 |
| mRNA |
Ki8751 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
7e-07 |
| mRNA |
Axitinib |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
3e-08 |
| mRNA |
Methotrexate |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
4e-07 |
| mRNA |
regorafenib |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
5e-07 |
| mRNA |
linifanib |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
7e-08 |
| mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
1e-07 |
| mRNA |
Gemcitabine |
gCSI |
pan-cancer |
AAC |
0.2 |
0.0002 |
| mRNA |
BRD-K30748066 |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
0.05 |